SCHEMBL23937909

SCHEMBL23937909

Cn1nc(O)c2c1CCSC2

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.30
PARP15 Q460N3 1/20 0.30
PARP3 Q9Y6F1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21958679 0.87
SCHEMBL20952915 0.75
SCHEMBL21959597 0.74
SCHEMBL20674457 0.73 GRM5 (0.38)
SCHEMBL23937918 0.72 BRD4 (0.40) PARP1
SCHEMBL17505258 0.70 ALDH1A1 (0.43) PARP1
SCHEMBL23937897 0.67 PARP1 (0.33) PARP1PARP15PARP3
SCHEMBL21196044 0.64 CYP2C19 (0.34)
SCHEMBL21216436 0.63 SOD3 (0.35)
Bromide SCHEMBL21196019 0.62 SOD3 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed